Panbela Therapeutics Inc expected to post a loss of 22 cents a share - Earnings Preview

Panbela Therapeutics

09/11/2022 03:04

* Panbela Therapeutics Inc  PBLA.OQ   PBLA.O  is expected
to show
no change in quarterly revenue when it reports  results on
November 10. 
    * 
    * ​Refinitiv's mean analyst estimate for Panbela
Therapeutics Inc
is for a loss of 22 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Panbela
Therapeutics Inc is $9.5​, above​ its last closing price
of $0.12. ​​​

This summary was machine generated November 9 at 03:04 GMT.  All
figures in US dollars  unless otherwise stated